Daily bars for up to one year, weekly bars for the 5-year view. Averages are 50/200 trading days (10/40 weeks on the 5-year view). Triangles mark past earnings reports, colored by that day’s move; ticks mark ex-dividend dates — hover either for the date. Volume is the shaded bars under the price; switch on RSI or MACD above for a full-history oscillator panel, not just today’s reading.
Reader sentiment, not investment advice. One vote per visitor; click again to change it.
ALMR last changed hands at $38.13 (up 10.97%). At $2.65B, Alamar Biosciences is ranked #2584 by size among the 3132 stocks on BeStock.
The 52-week range is $18.85 to $38.54. Today's price is about 98% of the way from the low to the high.
4 analysts follow the stock and the average call is "buy". The mean target, $33.00, sits 13.5% under where the stock trades.
This summary is put together from the numbers on the page and updates when they do. It describes the data; it is not a forecast or a recommendation.
Composite of 2 factors below, ranked against the 3131 U.S. stocks BeStock covers.
Trading closer to its 52-week high than most peers scores higher.
4 analysts, consensus Buy.
How this is scored: each factor above is a 0–100 percentile rank against every other stock BeStock covers (or, for Wall Street, against the five-point Strong Buy–Sell scale). The overall grade is the plain average of whichever factors apply to this stock — no factor is weighted more than another. That average maps to a letter: A ≥ 85, B ≥ 70, C ≥ 50, D ≥ 30, otherwise F. Recomputed from the data on this page as prices and filings update — it describes where a stock ranks today, not a forecast, and not a BeStock recommendation to buy or sell.
ALMR is not currently one of the 10 holdings in BeStock Momentum, our rules-based momentum strategy.
Since 2021-01-04, the strategy has returned 389% (231.1% for the equal-weight average of BeStock’s coverage over the same stretch). Holdings can change any trading day, not just on a fixed schedule. Backtested performance, updated weekly — not a guarantee of future results, and not a BeStock recommendation.
What Wall Street analysts and Morningstar's fair-value model expect for the stock
Wall Street’s average 12-month target is $33.00, 13.5% below today’s price, with a consensus rating of Buy. Morningstar’s fair value model puts the stock at $43.96, so shares trade 13.3% below that estimate.
Figures are Wall Street analyst consensus and Morningstar’s independent fair-value model, sourced as noted above.
Price return over each window, from adjusted daily and weekly closes
| Indicator | Value | Signal |
|---|---|---|
| Price vs 20-day average | +19.5% | Bullish |
| Price vs 50-day average | +23.0% | Bullish |
| RSI (14) | 67.7 | Bullish |
| MACD (12,26,9) | 1.23 | Bullish |
| Bollinger band position | 105% | Neutral |
Standard indicator readings worked out from daily closes. They describe how the price has behaved, not where it is going.
Quote as of Oct 6, 2026 4:10 am ET. Prices can lag the live tape. This is background information, not a recommendation.
Ranks are among the 3,131 or so U.S.-listed stocks BeStock covers, recalculated whenever prices refresh. A tile is left out when the measure does not apply, such as yield for a stock that pays no dividend.
$38.13 is the latest print for ALMR, a move of +10.97% against yesterday's close of $34.36. Today's low and high so far: $33.36 and $38.38.
Equity value comes to $2.65B at the current price. By that measure it is number 2584 of the 3132 names in our coverage.
The year's floor is $18.85 and the ceiling $38.54. Shares are 1.1% away from that ceiling.
Our data shows no dividend paid by Alamar Biosciences over the trailing twelve months.
Of 4 analysts, 75% say buy, 25% hold and 0% sell. Price targets average $33.00, with the most cautious at $31.00 and the most optimistic at $35.00.
BeStock publishes market data and analysis for information only. Nothing here is investment advice or a solicitation to buy or sell any security, and none of it is tailored to your financial situation, goals, or risk tolerance. Quotes may be delayed and figures can contain errors; check primary sources before you trade. How we source and calculate these pages.
No comments yet — be the first to weigh in on ALMR.